2 weeks VRTX’s Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales Zacks
Vertex reports mixed fourth-quarter 2024 results as earnings miss estimates while revenues beat the same. Trikafta/Kaftrio drive year-over-year sales.
Earnings · Pharmaceuticals · Vertex (VRTX)
X